Clinical trial
Augmenting Response to Entecavir With Peginterferon a-2a for the Treatment of…
NCT00877760 · Foundation for Liver Research, Other · Completed
Key facts
| NCT number | NCT00877760 |
|---|---|
| Title | Augmenting Response to Entecavir With Peginterferon a-2a for the Treatment of HBeAg-positive Chronic Hepatitis B |
| Official title | Augmenting Response to Entecavir Using a Temporary Peginterferon Alpha-2a add-on Strategy for the Treatment of HBeAg-positive Chronic Hepatitis B |
| Acronym | ARES |
| Lead sponsor | Foundation for Liver Research, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis B |
| Intervention type | Drug |
| Interventions | pegylated interferon a-2a, Entecavir |
| Enrollment | 184 |
| Start date | Aug 1, 2009 |
| Primary completion | Jul 1, 2013 |
| Completion | Jul 1, 2013 |
| First posted | Apr 8, 2009 |
| Last update posted | Mar 28, 2014 |
| Countries | China, Netherlands, Poland, Romania, Turkey (Türkiye) |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: